NTT Docomo took part in a series A round for VR technology developer Hikky that stands at $57.1m so far while cancer therapy developer Ankyra raised $45m from investors including GV.

Kindred Ventures led the LeFrak-backed healthcare services provider's series E round valuing it at $4.6bn.

Bristol Myers Squibb and Pfizer Ventures are part of a PIPE financing backing the fibrosis and neurodegenerative disease drug developer's reverse takeover.

SAIC Motor’s Hengxu Capital unit took part in the latest round for the Legend Capital-backed X-ray system manufacturer following about $43m in earlier funding.

Glico and Physician Partners helped health test provider Viome raise $54m while real estate data provider CompStak and battery swapping technology developer Ample each bagged $50m.

The China-focused SK Biopharmaceuticals spinoff raised cash in a series A round led by 6 Dimensions Capital that included Ruentex Group.

The medical data aggregator increased its overall funding from $95m to $200m and has secured three new health system patners.

Deep Nishar has departed from his SBIA senior managing partner role to help develop enterprise software, biotech and life sciences pipelines at the venture firm.

Alexandria Venture Investments was among the participants in a series B round which will support clinical trials for Acrivon's lead oncology drug candidate.

The venture firm has hired Jayson Punwani a year after he left his partner position at corporate venturing unit Takeda Ventures.